← back to search

Yi Wen

Guangzhou University of Chinese Medicine · CN
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research focused on Oncology and Nomogram, with related work in Proportional hazards model, Berberine, Basal cell. Notable publications include 'Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties', 'Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice', and 'Construction and Validation of a Ferroptosis-Related Prognostic Model for Gastric Cancer'.
h-index
citations
594
works
23
NIH funding
primary concept
email

Recent publications

CCL26–CX3CR1 Axis Mediates a Feedback Loop between Cancer Cell and PMN-MDSCs to Promote CD8 <sup>+</sup> T Cell Exhaustion during Stomach Carcinogenesis
Research 2025cited by 1position: middledoi
Assessment of the targeted effect of Sijunzi decoction on the colorectal cancer microenvironment via the ESTIMATE algorithm
PLoS ONE 2022cited by 13position: lastdoi
Mass Cytometry and Single-Cell Transcriptome Analyses Reveal the Immune Cell Characteristics of Ulcerative Colitis
Frontiers in Molecular Biosciences 2022cited by 7position: middledoi
The Short Health Scale: A Valid and Reliable Quality-of-Life Scale for Mainland Chinese Patients with Inflammatory Bowel Disease
Palliative Medicine Reports 2022cited by 1position: middledoi
Construction and Validation of a Ferroptosis-Related Prognostic Model for Gastric Cancer
Journal of Oncology 2021cited by 52position: middledoi
Current Evidence and Future Perspective of Accuracy of Artificial Intelligence Application for Early Gastric Cancer Diagnosis With Endoscopy: A Systematic and Meta-Analysis
Frontiers in Medicine 2021cited by 41position: middledoi
A glycolysis-related gene pairs signature predicts prognosis in patients with hepatocellular carcinoma
PeerJ 2020cited by 37position: middledoi
Construction and validation of a TP53-associated immune prognostic model for gastric cancer
Genomics 2020cited by 34position: middledoi
Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer
DNA and Cell Biology 2020cited by 29position: middledoi
A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer
International Immunopharmacology 2020cited by 26position: middledoi
Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials
Trials 2020cited by 14position: middledoi
Construction of a 13‐microRNA‐based signature and prognostic nomogram for predicting overall survival in patients with hepatocellular carcinoma
Hepatology Research 2020cited by 10position: middledoi
The effect of the fortifying the spleen, clearing heat, activating blood method on chronic atrophic gastritis: a real-world study
medRxiv 2020cited by 0position: middledoi
&lt;i&gt;LYZ&lt;/i&gt; and &lt;i&gt;SST&lt;/i&gt; Prevent the Progression of Chronic Inflammation into Adenocarcinoma in the Stomach
SSRN Electronic Journal 2020cited by 0position: middledoi
CXCR4 Negatively Correlates with NKT Cell Infiltration During Gastric Precancerous Lesions Progression to Early Gastric Cancer
Research Square 2020cited by 0position: middledoi
Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice
Biomedicine & Pharmacotherapy 2019cited by 62position: middledoi
Relationship between long‐term use of proton pump inhibitors and risk of gastric cancer: A systematic analysis
Journal of Gastroenterology and Hepatology 2019cited by 44position: middledoi
Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma
Oral Oncology 2019cited by 42position: middledoi
Corrigendum to “Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice” [Biomed. Pharmacother. 118 (2019) 109206]
Biomedicine & Pharmacotherapy 2019cited by 1position: middledoi
Development of a Traditional Chinese Medicine Syndrome‐Specific Scale for Ulcerative Colitis: The Large Intestine Dampness‐Heat Syndrome Questionnaire
Evidence-based Complementary and Alternative Medicine 2018cited by 19position: middledoi
Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties
Health and Quality of Life Outcomes 2017cited by 103position: middledoi
Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis
BMC Cancer 2017cited by 39position: middledoi
Hepatocyte growth factor is a prognostic marker in patients with colorectal cancer: a meta-analysis
Oncotarget 2017cited by 19position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xinlin Chen · Guangzhou University of Chinese Medicine12 papers (2017–2022)Fengbin Liu · Guangzhou University of Chinese Medicine11 papers (2017–2022)Xiaotao Jiang · Guangzhou University of Chinese Medicine10 papers (2019–2025)Zhihua Zheng · Sun Yat-sen University9 papers (2020–2021)Kechao Nie · Guangzhou University of Chinese Medicine9 papers (2020–2021)Jinglin Pan · Guangzhou University of Chinese Medicine9 papers (2020–2021)Fengbin Liu · Guangzhou University of Chinese Medicine8 papers (2019–2025)Kailin Jiang · Guangzhou University of Chinese Medicine8 papers (2019–2021)Peiwu Li · Guangzhou University of Chinese Medicine8 papers (2019–2021)Yanhua Yan · Guangzhou University of Chinese Medicine7 papers (2020–2021)Kunhai Zhuang · Guangzhou University of Chinese Medicine5 papers (2020–2025)Peiwu Li · Guangzhou University of Chinese Medicine4 papers (2020–2025)Tian-Wen Liu · Guangzhou University of Chinese Medicine3 papers (2017–2018)Zhengkun Hou · Guangzhou University of Chinese Medicine3 papers (2017–2020)Shui-lian Zhu · Guangzhou University of Chinese Medicine3 papers (2017–2019)Yufeng Liu · Guangzhou University of Chinese Medicine3 papers (2019–2020)Yufeng Liu · Yale Cancer Center3 papers (2020–2025)Bin Peng · Anhui Agricultural University3 papers (2020–2022)Shijing Zhang · Guangzhou University of Chinese Medicine3 papers (2020–2022)Yue Hu · Guangzhou University of Chinese Medicine3 papers (2017–2018)